 Limited heterogeneity HLA class II contribution susceptibility arthritis positive associations patients rheumatoid arthritis RA HLA class II epitope molecules possibility associations present minority patients antigens eighty patients classical definite RA controls HLA-DR DQ DP types DNA-based system sequence-specific oligonucleotides amplified class II alleles polymerase chain reaction expected associations relative risk relative risk individuals alleles age- race-matched controls significant association RA group patients controls novel associations DR DQ DP alleles evident contrast previous studies third allelic hypervariable region DR beta chain similar amino acid sequence many molecules results correlation susceptibility determinant HLA-linked susceptibility cases RA